🇺🇸 FDA

Intelligence · Patent portfolio

Alnylam Netherlands Patents

Full USPTO pharma patent portfolio for Alnylam Netherlands — grant dates, expiration, and drug cross-links.

Patents
379
Expiring ≤24m
4

Quick answer

Alnylam Netherlands has 379 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 4 expire within 24 months — use filters for patent-cliff planning.

Page 6 of 8

  1. US 9029338

    Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus

    Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9012498

    Biodegradable lipids for the delivery of active agents

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9012624

    Compositions and methods for inhibiting expression of a gene from the JC virus

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9006197

    Compositions and methods for inhibiting expression of Eg5 and VEGF genes

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9000143

    Compositions and methods for inhibiting expression of IKK-B gene

    Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8993746

    Nuclease resistant double-stranded ribonucleic acid

    Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8987377

    Poly(amide) polymers for the delivery of oligonucleotides

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8987227

    Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8962580

    Chemical modifications of monomers and oligonucleotides with cycloaddition

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8957223

    Ligand-conjugated monomers

    Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8889644

    GNAQ targeted dsRNA compositions and methods for inhibiting expression

    Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8877917

    Glycoconjugates of RNA interference agents

    Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8877726

    Method and medicament for inhibiting the expression of a given gene

    Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8859516

    Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes

    Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8859750

    RNAi modulation of RSV and therapeutic uses thereof

    Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8828956

    Carbohydrate conjugates as delivery agents for oligonucleotides

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8809516

    Therapeutic compositions

    Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8809292

    Compositions and methods for inhibiting expression of the PCSK9 gene

    Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8796436

    Modified iRNA agents

    Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8791250

    Compositions and methods for inhibiting expression of the HAMP gene

    Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8765932

    Compositions and methods for inhibiting expression of XBP-1 gene

    Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8754201

    Therapeutic compositions

    Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8741866

    Compositions and methods for inhibiting expression of transthyretin

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8729037

    Method and medicament for inhibiting the expression of a given gene

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8664193

    Compositions and methods for inhibiting expression of factor VII gene

    Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8614198

    Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use

    Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8598139

    Lipid formulated dsRNA targeting the PCSK9 gene

    Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8598333

    SiRNA silencing of genes expressed in cancer

    Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8592570

    Compositions and methods for inhibiting expression of an RNA from West Nile virus

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8592571

    RNAi modulation of APOB and uses thereof

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8575327

    Conserved HBV and HCV sequences useful for gene silencing

    Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8546143

    Compositions and methods for inhibiting expression of a target gene

    Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8546554

    Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene

    Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8507663

    Compositions and methods for inhibiting expression of CD274/PD-L1 gene

    Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8507661

    Modified iRNA agents

    Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8507455

    Folate conjugates

    Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8470988

    Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety

    Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8470799

    Compositions and methods for inhibiting expression of the HAMP gene

    Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8450467

    Carbohydrate conjugates as delivery agents for oligonucleotides

    Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8445665

    Therapeutic compositions

    Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8420799

    Therapeutic compositions

    Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8410073

    Methods and compositions for prevention or treatment of RSV infection

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8410261

    Compositions and methods for inhibiting expression of a gene from the JC virus

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8404862

    Ligand-conjugated monomers

    Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8350021

    Conserved HBV and HCV sequences useful for gene silencing

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8344126

    Compositions and methods for inhibiting expression of XBP-1 gene

    Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8344125

    Modified iRNA agents

    Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8334273

    Compositions and methods for inhibiting expression of factor VII gene

    Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Alnylam Netherlands have?

379 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Alnylam Netherlands patents expire?

4 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.